Generate a tailored SOP for Dr. Dafna Bar Sagi. Improve your application with a focused, well-structured draft.
Dafna Bar-Sagi is the Executive Vice President, Vice Dean for Science, and Chief Scientific Officer at NYU Grossman School of Medicine. She holds the title of Saul J. Farber Professor of Biochemistry and Molecular Pharmacology. Her research laboratory investigates oncogene function in pancreatic cancer, focusing on signaling pathways that are often altered in various cancers. Specifically, her work centers on the deregulated signaling axis involving the Ras protein, which plays a crucial role in cell proliferation and differentiation. Bar-Sagi's ongoing projects include developing cell and animal models to study the role of inflammation in Ras-driven tumorigenesis. She is dedicated to defining how specific molecular alterations contribute to cancer initiation and progression. The ultimate goal of her research is to leverage this information for new diagnostic and therapeutic strategies against pancreatic cancer. She has extensively published and been cited in her field, highlighting her contributions to understanding cancer biology and treatment.
Open Program in Biomedical Sciences (Vilcek Institute) covers departments like Biochemistry, Pathology, Neuroscience, Microbiology, etc.